Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Carpal Tunnel Clinical Trials
Carpal Tunnel clinical trials are recruiting across 86 cities. Here are the cities with the most active studies:
Carpal Tunnel Trial Phases
57 research organizations are sponsoring carpal tunnel trials.
About Carpal Tunnel
Carpal tunnel syndrome occurs when the median nerve is compressed as it passes through the carpal tunnel in the wrist. Symptoms include numbness, tingling, and weakness in the hand. Treatment ranges from wrist splinting and corticosteroid injections to surgical release.
Clinical trials are advancing new treatments for carpal tunnel. Currently, 61 studies are recruiting a combined 116,077 participants across the United States. Research is being conducted by 57 organizations including Intermountain Health Care, Inc., National Institute of Allergy and Infectious Diseases (NIAID), University of Wisconsin, Madison and 54 others.
2026 Carpal Tunnel Research Landscape
As of July 2026, the carpal tunnel clinical trial landscape includes 61 actively recruiting studies across 86 cities in the United States. These studies are collectively seeking 116,077 participants, with an average enrollment target of 1,903 per study.
The research spans multiple phases of development: 29 studies are in NA, 10 studies are in PHASE1, 6 studies are in PHASE4, 3 studies are in EARLY_PHASE1, 2 studies are in PHASE2, 1 study is in PHASE3. The presence of Phase 3 trials indicates that some carpal tunnel treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 57 different organizations, including Intermountain Health Care, Inc., National Institute of Allergy and Infectious Diseases (NIAID), University of Wisconsin, Madison, Guerbet, Georgia State University, and 52 others. The large number of sponsors reflects significant research interest and investment in carpal tunnel treatment advancement.
Geographically, carpal tunnel trials are most concentrated in Baltimore, Maryland (6 trials); Chicago, Illinois (4 trials); Scottsdale, Arizona (3 trials); Houston, Texas (3 trials); Los Angeles, California (3 trials) and 7 other cities.
Featured Carpal Tunnel Studies
Highlighted recruiting studies for carpal tunnel, selected by enrollment size and research scope.
Precision Genomics Medicine Biobank
The immediate goal of this study is to collect biological samples (i.e., tissue and/or fluid), clinical information, and laboratory data from disease and non-disease subjects seen at Intermountain Healthcare affiliated facilities. The long-term goal is to annotate tissue and/or fluid biomarker data to clinical information and laboratory data for the purpose of improving health care delivery and pr...
Detection and Characterization of Host Defense Defects
This protocol is designed to evaluate selected patients with documented recurrent or unusual infections and their family members for clinical and laboratory correlates of immune abnormalities. It allows long term follow up of patients with host defense defects and permits the periodic study of their blood, urine, saliva, skin, stool and vaginal specimens or wound drainage from such patients or the...
Registry for CADASIL
This study is being done in order to create a registry (list) of people interested in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) research. It may be that you have a family member or other loved one with CADASIL, or that you may have CADASIL or are at risk. Participation means that your name will be added to a list of people who will be invi...
Frequently Asked Questions About Carpal Tunnel Clinical Trials
Are there carpal tunnel clinical trials near me?
Yes, there are 61 carpal tunnel clinical trials currently recruiting across 86+ cities in the United States, including Baltimore, Maryland; Chicago, Illinois; Scottsdale, Arizona. Browse the studies above to find one at a location convenient for you.
How do I join a carpal tunnel clinical trial?
To join a carpal tunnel clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are carpal tunnel clinical trials free?
Yes, participation in carpal tunnel clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of carpal tunnel treatments are being studied?
Current carpal tunnel clinical trials are testing a range of approaches across NA (29 studies), PHASE1 (10 studies), PHASE4 (6 studies), EARLY_PHASE1 (3 studies), PHASE2 (2 studies), PHASE3 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 57 research organizations.
Is it safe to participate in carpal tunnel clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 17, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 17, 2026 · Data from ClinicalTrials.gov